Quantum Biopharma (QNTM) Notes Payables (2019 - 2026)
Quantum Biopharma recorded quarterly Notes Payables of $300549.0 in Q1 2026, down 76.89% quarter-over-quarter from $1.3 million in Q4 2025, and down 72.37% year-over-year from $1.1 million in Q1 2025.
Quantum Biopharma's Notes Payables history runs 8 years deep, the most recent figure standing at $300549.0 for Q1 2026.
- In Q1 2026, Notes Payables fell 72.37% year-over-year to $300549.0; the TTM figure through Mar 2026 stood at $300549.0 (down 72.37% YoY), while the FY2025 annual figure was $1.3 million, up 110.1% from the prior year.
- Notes Payables came in at $300549.0 for Q1 2026 at Quantum Biopharma, down from $1.3 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $2.0 million in Q3 2025 to a low of $300549.0 in Q1 2022.
- A 5-year average of $683187.2 and a median of $300549.0 in 2022 frame the typical range for Notes Payables.
- Across the five-year window, Notes Payables surged 557.23% in 2025 and plunged 72.37% in 2026, its largest moves.
- Quantum Biopharma's Notes Payables stood at $300549.0 in 2022, then changed by 0.0% to $300549.0 in 2023, then soared by 105.97% to $619029.0 in 2024, then soared by 110.1% to $1.3 million in 2025, then sank by 76.89% to $300549.0 in 2026.
- According to Business Quant data, Notes Payables over the past three periods registered $300549.0, $1.3 million, and $2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300,549.00 |
| Dec 31, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.98 Mn |
| Jun 30, 2025 | 1.94 Mn |
| Mar 31, 2025 | 1.09 Mn |
| Dec 31, 2024 | 619,029.00 |
| Sep 30, 2024 | 300,549.00 |
| Jun 30, 2024 | 615,562.00 |
| Sep 30, 2023 | 300,549.00 |
| Jun 30, 2023 | 300,549.00 |
| Mar 31, 2023 | 300,549.00 |
| Dec 31, 2022 | 300,549.00 |
| Sep 30, 2022 | 300,549.00 |
| Jun 30, 2022 | 300,549.00 |
| Mar 31, 2022 | 300,549.00 |
| Dec 31, 2021 | 300,549.00 |
| Sep 30, 2021 | 300,549.00 |
| Jun 30, 2021 | 300,549.00 |
| Mar 31, 2021 | 358,549.00 |
| Dec 31, 2020 | 384,647.00 |
| Sep 30, 2020 | 902,088.05 |
| Jun 30, 2020 | 1.32 Mn |
| Mar 31, 2020 | 1.55 Mn |
| Dec 31, 2019 | 1.45 Mn |